Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Maher

Showing results (1091-1100 of 1,158) with videos related to

Pageof 116
Sort By:
American Journal of Respiratory and Critical Care Medicine|July 20, 2021
Patient-centered Outcomes Research in Interstitial Lung Disease: An Official American Thoracic Society Research StatementKerri I Aronson, Sonye K Danoff, Anne-Marie Russell, et al.
Science Translational Medicine|September 27, 2019
Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosisBenjamin Ng, Jinrui Dong, Giuseppe D'Agostino, et al.
The Lancet. Respiratory Medicine|July 18, 2024
Cluster analysis of blood biomarkers to identify molecular patterns in pulmonary fibrosis: assessment of a multicentre, prospective, observational cohort with independent validationHernan P Fainberg, Yuben Moodley, Isaac Triguero, et al.
The European Respiratory Journal|November 20, 2020
Target inhibition of galectin-3 by inhaled TD139 in patients with idiopathic pulmonary fibrosisNikhil Hirani, Alison C MacKinnon, Lisa Nicol, et al.
The Lancet. Digital Health|November 4, 2022
Forced vital capacity trajectories in patients with idiopathic pulmonary fibrosis: a secondary analysis of a multicentre, prospective, observational cohortHernan P Fainberg, Justin M Oldham, Philip L Molyneau, et al.
Nature Medicine|April 11, 2024
Feasibility of functional precision medicine for guiding treatment of relapsed or refractory pediatric cancersArlet M Acanda De La Rocha, Noah E Berlow, Maggie Fader, et al.
American Journal of Respiratory and Critical Care Medicine|April 4, 2024
Genetics and Genomics of Pulmonary Fibrosis: Charting the Molecular Landscape and Shaping Precision MedicineAyodeji Adegunsoye, Jonathan A Kropski, Juergen Behr, et al.
The European Respiratory Journal|February 16, 2019
A randomised, placebo-controlled study of omipalisib (PI3K/mTOR) in idiopathic pulmonary fibrosisPauline T Lukey, Stephen A Harrison, Shuying Yang, et al.
The European Respiratory Journal|November 30, 2018
Predicting outcomes in rheumatoid arthritis related interstitial lung diseaseJoseph Jacob, Nikhil Hirani, Coline H M van Moorsel, et al.
Nature Communications|September 12, 2020
Author Correction: The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesisHannah V Woodcock, Jessica D Eley, Delphine Guillotin, et al.
Pageof 116

Showing results (1091-1100 of 1,158) with videos related to

Sort By:
Pageof 116
American Journal of Respiratory and Critical Care Medicine|July 20, 2021
Patient-centered Outcomes Research in Interstitial Lung Disease: An Official American Thoracic Society Research StatementKerri I Aronson, Sonye K Danoff, Anne-Marie Russell, et al.
Science Translational Medicine|September 27, 2019
Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosisBenjamin Ng, Jinrui Dong, Giuseppe D'Agostino, et al.
The Lancet. Respiratory Medicine|July 18, 2024
Cluster analysis of blood biomarkers to identify molecular patterns in pulmonary fibrosis: assessment of a multicentre, prospective, observational cohort with independent validationHernan P Fainberg, Yuben Moodley, Isaac Triguero, et al.
The European Respiratory Journal|November 20, 2020
Target inhibition of galectin-3 by inhaled TD139 in patients with idiopathic pulmonary fibrosisNikhil Hirani, Alison C MacKinnon, Lisa Nicol, et al.
The Lancet. Digital Health|November 4, 2022
Forced vital capacity trajectories in patients with idiopathic pulmonary fibrosis: a secondary analysis of a multicentre, prospective, observational cohortHernan P Fainberg, Justin M Oldham, Philip L Molyneau, et al.
Nature Medicine|April 11, 2024
Feasibility of functional precision medicine for guiding treatment of relapsed or refractory pediatric cancersArlet M Acanda De La Rocha, Noah E Berlow, Maggie Fader, et al.
American Journal of Respiratory and Critical Care Medicine|April 4, 2024
Genetics and Genomics of Pulmonary Fibrosis: Charting the Molecular Landscape and Shaping Precision MedicineAyodeji Adegunsoye, Jonathan A Kropski, Juergen Behr, et al.
The European Respiratory Journal|February 16, 2019
A randomised, placebo-controlled study of omipalisib (PI3K/mTOR) in idiopathic pulmonary fibrosisPauline T Lukey, Stephen A Harrison, Shuying Yang, et al.
The European Respiratory Journal|November 30, 2018
Predicting outcomes in rheumatoid arthritis related interstitial lung diseaseJoseph Jacob, Nikhil Hirani, Coline H M van Moorsel, et al.
Nature Communications|September 12, 2020
Author Correction: The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesisHannah V Woodcock, Jessica D Eley, Delphine Guillotin, et al.
Pageof 116